Quick Answer
10x Genomics, Inc. reported Operating Income of -$60.98 million for fiscal year 2025.
10x Genomics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$60.98M | +68.7% |
| 2024 | -$194.56M | +26.7% |
| 2023 | -$265.33M | -58.0% |
| 2022 | -$167.94M | -221.4% |
| 2021 | -$52.25M | +90.2% |
| 2020 | -$534.14M | -1647.1% |
| 2019 | -$30.57M | +72.4% |
| 2018 | -$110.76M | -502.8% |
| 2017 | -$18.38M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.24M | +22.3% | -207.0% |
| June 30, 2025 | $30.13M | +172.2% | +176.6% |
| March 31, 2025 | -$39.33M | +36.0% | +5.2% |
| September 30, 2024 | -$41.48M | +56.2% | +0.6% |
| June 30, 2024 | -$41.74M | +34.1% | +32.1% |
| March 31, 2024 | -$61.50M | -18.3% | +35.1% |
| September 30, 2023 | -$94.80M | -137.0% | -49.6% |
| June 30, 2023 | -$63.36M | -0.4% | -21.9% |
- 10x Genomics, Inc. showed an increase of +68.7% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, 10x Genomics, Inc.’s operating income has declined by 231.9% (from -$18.38 million to -$60.98 million).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: